In summary, HIV/AIDS-associated disruption of oral, intestinal and genital epithelia is still an issue with antiretroviral therapy, possibly because of residual HIV infection of intramucosal CD4 + T lymphocytes, macrophages, Langerhans/dendritic cells and/or HIV/AIDS-initiated chronic inflammation. This evidence concerns the gene CD4 and HIV infectious disease.